Neurology
News
Deferoxamine does not improve 90-day outcomes after ICH
HONOLULU – The drug is safe, and data suggest that it could improve 180-day outcomes.
News
In California, opioids most often prescribed in low-income, mostly white areas
Opioid-related overdose deaths are highest in low-income white areas.
News
Cilostazol plus aspirin or clopidogrel reduces the risk of recurrent stroke
HONOLULU – Dual therapy with cilostazol and aspirin or clopidogrel did not increase the risk of serious bleeding.
News
Intensive insulin added no benefit for hyperglycemia after ischemic stroke
Results from a large RCT showed intensive and standard insulin regimens produced similar clinical outcomes after an acute ischemic stroke.
News
Statins cut vascular events in elderly patients
Analysis challenges current practice of discontinuation after age 75 years.
Clinical
When is it safe to resume anticoagulation in my patient with hemorrhagic stroke?
Robust scientific data on when to resume anticoagulation after ICH does not exist.
Public Policy
Defeating the opioid epidemic
U.S. Surgeon General Jerome M. Adams says the opioid epidemic is his primary focus.
News
Benefit of thrombectomy may be universal
The proportional benefit of thrombectomy is uniform among various subgroups of patients with acute ischemic stroke.
News
Obesity paradox applies to post-stroke mortality
All Content
Prioritize oral route for inpatient opioids with subcutaneous route as alternative
Can adoption of a local opioid standard of practice for hospitalized patients reduce intravenous and overall opioid exposure while providing...